Showing results (1-10 of 30) with videos related to

Sort By:
Pageof 3
Critical Reviews in Oncology/Hematology|May 23, 2024
Role of radiation in chimeric antigen receptor T-cell therapy for patients with relapsed/refractory non-Hodgkin lymphoma: Current studies and future prospectsLingzi Yu, Rui Zou, Jiajie He, et al.
Therapeutic Advances in Medical Oncology|August 22, 2025
Influence of the gut microbiome on lymphoma treatment: current evidence and future therapeutic directionsJiajie Tu, Lingzi Yu, Rui Zou, et al.
The Journal of Biological Chemistry|April 13, 2013
Transcriptional regulation of serine/threonine protein kinase (AKT) genes by glioma-associated oncogene homolog 1Nitin K Agarwal, Changju Qu, Kranthi Kunkalla, et al.
Journal of Gastrointestinal Oncology|May 17, 2024
Computer-aided diagnostic system with automated deep learning method based on the AutoGluon framework improved the diagnostic accuracy of early esophageal cancerXin Gao, Jiaxi Lin, Changju Qu, et al.
Frontiers in Immunology|June 9, 2023
Efficacy and safety of chimeric antigen receptor T cell therapy in relapsed/refractory diffuse large B-cell lymphoma with different HBV status: a retrospective study from a single centerDanqing Kong, Nana Ping, Xin Gao, et al.
Annals of Palliative Medicine|October 11, 2021
Multiple blood parameters may serve as a warning to immunochemotherapy-related interstitial lung disease in B-cell lymphomaFan Xia, Hailing Liu, Haizhou Zhang, et al.
Frontiers in Pharmacology|September 8, 2023
Body mass index-associated responses to an ABVD-like regimen in newly-diagnosed patients with Hodgkin lymphomaMin Hu, Yiduo Ding, Haizhou Zhang, et al.
Annals of Hematology|February 2, 2013
Functional inhibition of BCL2 is needed to increase the susceptibility to apoptosis to SMO inhibitors in diffuse large B-cell lymphoma of germinal center subtypeKranthi Kunkalla, Yadong Liu, Changju Qu, et al.
Hematological Oncology|July 20, 2022
Dual epigenetic agents plus rituximab-gemcitabine-oxaliplatin as salvage treatment in relapsed/refractory diffuse large B-cell lymphoma patients failure of salvage chemotherapyChangju Qu, Nana Ping, Danqing Kong, et al.
Biological & Pharmaceutical Bulletin|July 8, 2010
A new cyclooxygenase-2 inhibitor, (1E,4E)-1,5-bis(2-bromophenyl)penta-1,4-dien-3-one (GL63) suppresses cyclooxygenase-2 gene expression in human lung epithelial cancer cells: coupled mRNA stabilization and posttranscriptional inhibitionJian Xiao, Yi Tan, Yunbao Pan, et al.
Pageof 3